Newsletter | September 13, 2021

09.13.21 -- Becoming A Clinical-Stage Biotech

Exclusive Articles
Becoming A Clinical-Stage Biotech

A Q&A with Laura Indolfi, CEO and cofounder of PanTher Therapeutics, which recently closed its Series A funding round and is preparing for its first clinical trials.

How Will Clinical Trial Recruitment Be Influenced By The Virtual Environment Fostered During The COVID-19 Pandemic?

See the answer from Mitchell Katz, Ph.D., who is the VP of development operations at Ferring Pharmaceuticals.

What Biopharmas Need To Know About Genetic Data Privacy

Although accessing genomic data provides biopharmas valuable insight to develop therapeutically effective drugs, the access to such data also escalates the possibility of exposing consumers’ personal and private information.

Does Back To The Office Also Mean Back To Travel For Conferences?

Scott Nogi, VP of business operations for Abeona Therapeutics, and James Mackay, Ph.D., founder, president, and CEO of Aristea Therapeutics, discuss Apple’s decision to delay returning to in-office operations until October 2021. As the conversation moves to travel amidst the Delta variant, Britt Beyers, SVP of HR for Kyowa Kirin North America, weighs in.

September 2021 Digital Edition

Inside you will find more on:

  • The Role Of Patients In Product Development
  • The Tales Of First-Time CEOs
  • Companies To Watch
  • Risk Management In Pharma

View the digital edition.

Contribute To Life Science Leader
Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director.